Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma

Improved therapies for individuals with head and neck squamous cell carcinoma (HNSCC) may be developed by identification of appropriate biomarkers. The aim of this study was to evaluate the usefulness of serum midkine measurement as a biomarker for HNSCC. Pretreatment serum midkine concentrations we...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Med
Glavni autori: Yamashita, Taku, Shimada, Hideaki, Tanaka, Shingo, Araki, Koji, Tomifuji, Masayuki, Mizokami, Daisuke, Tanaka, Nobuaki, Kamide, Daisuke, Miyagawa, Yoshihiro, Suzuki, Hiroshi, Tanaka, Yuya, Shiotani, Akihiro
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2016
Teme:
Clinical Cancer Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4799940/
https://ncbi.nlm.nih.gov/pubmed/26798989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.600
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items